78 related articles for article (PubMed ID: 32561749)
1. A clinically and genomically annotated nerve sheath tumor biospecimen repository.
Pollard K; Banerjee J; Doan X; Wang J; Guo X; Allaway R; Langmead S; Slobogean B; Meyer CF; Loeb DM; Morris CD; Belzberg AJ; Blakeley JO; Rodriguez FJ; Guinney J; Gosline SJC; Pratilas CA
Sci Data; 2020 Jun; 7(1):184. PubMed ID: 32561749
[TBL] [Abstract][Full Text] [Related]
2. Targeted STAT1 therapy for LZTR1-driven peripheral nerve sheath tumor.
Ivanisevic T; Steklov M; Lechat B; Cawthorne C; Gsell W; Velde GV; Deroose C; Van Laere K; Himmelreich U; Sewduth RN; Sablina AA
Cancer Commun (Lond); 2023 Dec; 43(12):1386-1390. PubMed ID: 37890861
[No Abstract] [Full Text] [Related]
3. Activation of Receptor Tyrosine Kinases Mediates Acquired Resistance to MEK Inhibition in Malignant Peripheral Nerve Sheath Tumors.
Wang J; Pollard K; Calizo A; Pratilas CA
Cancer Res; 2021 Feb; 81(3):747-762. PubMed ID: 33203698
[TBL] [Abstract][Full Text] [Related]
4. Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.
Wang J; Pollard K; Allen AN; Tomar T; Pijnenburg D; Yao Z; Rodriguez FJ; Pratilas CA
Cancer Res; 2020 Dec; 80(23):5367-5379. PubMed ID: 33032988
[TBL] [Abstract][Full Text] [Related]
5. Special Issue: "Genomics and Models of Nerve Sheath Tumors".
Hirbe AC; Dodd RD; Pratilas CA
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32882803
[TBL] [Abstract][Full Text] [Related]
6. From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor.
Lemberg KM; Wang J; Pratilas CA
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32599735
[TBL] [Abstract][Full Text] [Related]
7. Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.
Fisher MJ; Shih CS; Rhodes SD; Armstrong AE; Wolters PL; Dombi E; Zhang C; Angus SP; Johnson GL; Packer RJ; Allen JC; Ullrich NJ; Goldman S; Gutmann DH; Plotkin SR; Rosser T; Robertson KA; Widemann BC; Smith AE; Bessler WK; He Y; Park SJ; Mund JA; Jiang L; Bijangi-Vishehsaraei K; Robinson CT; Cutter GR; Korf BR; ; Blakeley JO; Clapp DW
Nat Med; 2021 Jan; 27(1):165-173. PubMed ID: 33442015
[TBL] [Abstract][Full Text] [Related]
8. A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.
Nguyen HTL; Kohl E; Bade J; Eng SE; Tosevska A; Al Shihabi A; Tebon PJ; Hong JJ; Dry S; Boutros PC; Panossian A; Gosline SJC; Soragni A
Cell Rep Methods; 2024 May; 4(5):100772. PubMed ID: 38744290
[TBL] [Abstract][Full Text] [Related]
9. Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.
Mitchell DK; Burgess B; White EE; Smith AE; Sierra Potchanant EA; Mang H; Hickey BE; Lu Q; Qian S; Bessler W; Li X; Jiang L; Brewster K; Temm C; Horvai A; Albright EA; Fishel ML; Pratilas CA; Angus SP; Clapp DW; Rhodes SD
Clin Cancer Res; 2024 Mar; 30(5):1038-1053. PubMed ID: 38127282
[TBL] [Abstract][Full Text] [Related]
10. CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.
Wang J; Calizo A; Zhang L; Pino JC; Lyu Y; Pollard K; Zhang X; Larsson AT; Conniff E; Llosa NJ; Wood DK; Largaespada DA; Moody SE; Gosline SJ; Hirbe AC; Pratilas CA
Sci Adv; 2023 Nov; 9(47):eadg8876. PubMed ID: 38000020
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials.
Sundby RT; Rhodes SD; Komlodi-Pasztor E; Sarnoff H; Grasso V; Upadhyaya M; Kim A; Evans DG; Blakeley JO; Hanemann CO; Bettegowda C
Clin Trials; 2024 Feb; 21(1):40-50. PubMed ID: 37904489
[TBL] [Abstract][Full Text] [Related]
12. Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor.
Lemberg KM; Ali ES; Krecmerova M; Aguilar JMH; Alt J; Peters DE; Zhao L; Wu Y; Nuha N; Asara JM; Staedtke V; Pratilas CA; Majer P; Rais R; Ben-Sahra I; Slusher BS
Mol Cancer Ther; 2023 Dec; 22(12):1390-1403. PubMed ID: 37616542
[TBL] [Abstract][Full Text] [Related]
13. Brain MRI Segmentation using Template-Based Training and Visual Perception Augmentation.
Yeh FC
ArXiv; 2023 Aug; ():. PubMed ID: 37576127
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.
Larsson AT; Bhatia H; Calizo A; Pollard K; Zhang X; Conniff E; Tibbitts JF; Rono E; Cummins K; Osum SH; Williams KB; Crampton AL; Jubenville T; Schefer D; Yang K; Lyu Y; Pino JC; Bade J; Gross JM; Lisok A; Dehner CA; Chrisinger JSA; He K; Gosline SJC; Pratilas CA; Largaespada DA; Wood DK; Hirbe AC
Neuro Oncol; 2023 Nov; 25(11):2044-2057. PubMed ID: 37246765
[TBL] [Abstract][Full Text] [Related]
15. MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors.
Borcherding DC; Amin NV; He K; Zhang X; Lyu Y; Dehner C; Bhatia H; Gothra A; Daud L; Ruminski P; Pratilas CA; Pollard K; Sundby T; Widemann BC; Hirbe AC
Clin Cancer Res; 2023 Apr; 29(8):1592-1604. PubMed ID: 36799629
[TBL] [Abstract][Full Text] [Related]
16. CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors.
Wang J; Calizo A; Zhang L; Pino JC; Lyu Y; Pollard K; Zhang X; Larsson AT; Conniff E; Llosa N; Wood DK; Largaespada DA; Moody SE; Gosline SJ; Hirbe AC; Pratilas CA
bioRxiv; 2023 Feb; ():. PubMed ID: 36778419
[TBL] [Abstract][Full Text] [Related]
17. Malignant peripheral nerve sheath tumor: models, biology, and translation.
Somatilaka BN; Sadek A; McKay RM; Le LQ
Oncogene; 2022 Apr; 41(17):2405-2421. PubMed ID: 35393544
[TBL] [Abstract][Full Text] [Related]
18. Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor.
Bhalla AD; Landers SM; Singh AK; Landry JP; Yeagley MG; Myerson GSB; Delgado-Baez CB; Dunnand S; Nguyen T; Ma X; Bolshakov S; Menegaz BA; Lamhamedi-Cherradi SE; Mao X; Song X; Lazar AJ; McCutcheon IE; Slopis JM; Ludwig JA; Lev DC; Rai K; Torres KE
Lab Invest; 2022 Jun; 102(6):658-666. PubMed ID: 35228656
[TBL] [Abstract][Full Text] [Related]
19. RNA-sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas.
Imada EL; Strianese D; Edward DP; alThaqib R; Price A; Arnold A; Al-Hussain H; Marchionni L; Rodriguez FJ
Brain Pathol; 2022 Jan; 32(1):e13007. PubMed ID: 34297428
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 8 gain is associated with high-grade transformation in MPNST.
Dehner C; Moon CI; Zhang X; Zhou Z; Miller C; Xu H; Wan X; Yang K; Mashl J; Gosline SJ; Wang Y; Zhang X; Godec A; Jones PA; Dahiya S; Bhatia H; Primeau T; Li S; Pollard K; Rodriguez FJ; Ding L; Pratilas CA; Shern JF; Hirbe AC
JCI Insight; 2021 Mar; 6(6):. PubMed ID: 33591953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
